Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective

Empreu sempre aquest identificador per citar o enllaçar aquest ítem http://hdl.handle.net/10045/116822
Información del item - Informació de l'item - Item information
Títol: Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective
Autors: Vaismoradi, Mojtaba | Moe, Cathrine Fredriksen | Vizcaya-Moreno, M. Flores | Paal, Piret
Grups d'investigació o GITE: Enfermería Clínica (EC)
Centre, Departament o Servei: Universidad de Alicante. Departamento de Enfermería
Paraules clau: Ethics | Nurse | Harm | Medicines management | Patient safety | Pro re nata
Àrees de coneixement: Enfermería
Data de publicació: 23-de juliol-2021
Editor: SAGE Publications
Citació bibliogràfica: Clinical Ethics. 2022, 17(1): 5-13. https://doi.org/10.1177/14777509211034146
Resum: The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices have been suggested. The complicated caring situation surrounding the administration of pro re nata medications is intertwined with ethical issues affecting the consideration of the patient's wishes and interventions that override them. The patient's right of autonomy and treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical pro re nata medication administration. Education and training can help nurses avoid legal and ethical issues in pro re nata medicines management and improve the quality and safety of healthcare. Empirical research is needed to improve our understanding of this phenomenon in the multidisciplinary environment of medicines management.
URI: http://hdl.handle.net/10045/116822
ISSN: 1477-7509 (Print) | 1758-101X (Online)
DOI: 10.1177/14777509211034146
Idioma: eng
Tipus: info:eu-repo/semantics/article
Drets: © The Author(s) 2021
Revisió científica: si
Versió de l'editor: https://doi.org/10.1177/14777509211034146
Apareix a la col·lecció: INV - Enfermería Clínica - Artículos de Revistas

Arxius per aquest ítem:
Arxius per aquest ítem:
Arxiu Descripció Tamany Format  
ThumbnailVaismoradi_etal_2021_ClinEthics_final.pdfVersión final (acceso restringido)924,69 kBAdobe PDFObrir     Sol·licitar una còpia
ThumbnailVaismoradi_etal_2021_ClinEthics_accepted.pdfAccepted Manuscript (acceso abierto)263,54 kBAdobe PDFObrir Vista prèvia


Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.